CRABP2 and FABP5 Identified by 2D DIGE Profiling Are Upregulated in Human Bladder Cancer
Jin Bai-ye,Fu Guang-hou,Jiang Xue,Pan Hao,Zhou Dong-kai,Wei Xu-yong,Zhou Lin,Chung Lee,Zheng Shu-sen
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20130786
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:Bladder cancer (BC) is the second most common malignancy of the human genitourinary tract, and is characterized by a high recurrence rate and expensive treatment.1 There is still no ideal biomarker for diagnosing or monitoring human BC. In the present study, we used proteomics analysis, including two-dimensional fluorescence difference gel electrophoresis (2D DIGE) and matrix-assisted laser desorption ionization time of flight/time of flight mass spectrometry (MALDI-TOF/TOF MS), to identify new potential protein markers of BC. METHODS Materials and samples Cyanine dyes (Cy2, Cy3, and Cy5), immobiline pH gradient (IPG) strips, and IPG buffer were purchased from GE Amersham (Uppsala, Sweden). Based on the principle of prior informed consent, thirty-two paired samples of BC tissue and adjacent non-tumor tissue (more than 2 cm from the margins) were obtained from patients diagnosed with BC after a radical or partial cystectomy of a bladder tumor at the First Affiliated Hospital, Zhejiang University College of Medicine (Zhejiang, China). After surgical resection, the specimens were frozen in liquid nitrogen and stored at -80°C until use. Protein extractions and proteomics BC tissues and adjacent non-tumor tissues were ground into a fine powder in liquid nitrogen and subsequently solubilized in a cocktail of 7 mol/L urea, 2 mol/L thiourea, 4% CHAPS, 10 mmol/L Tris supplemented with 1×Halt protease inhibitor cocktail, 50 μg/ml DNase I, and 50 μg/ml RNase A. Protein estimation was carried out using the Coomassie Plus Protein Assay Reagent kit from Pierce with some modifications. Three pairs of tissue lysates were labeled with Cy2, Cy3, and Cy5 following the protocols in the Ettan DIGE User Manual (GE Amersham) with minor modifications. Isoelectric focusing (IEF) and SDS/PAGE were carried out to separate proteins according to their isoelectric points and molecular weights as previously described.2 For each sample pair, triplicate gels were run. IPG strips (13 cm, pH 3-10, nonlinear) were used. IEF was performed with the following parameters: (1) 30 V for 12 hours, (2) 500 V for 1 hour, (3) 1000 V for 1 hour, (4) 8000 V for 8 hours, and (5) 500 V for 4 hours. The 2D separation was conducted on 1-mm-thick 12.5% polyacrylamide gels using the Hofer SE 600 (GE Amersham) at 15 mA per gel for the first 20 minutes, followed by 30 mA per gel in the dark for the remaining part of the run. Digitalized images of gels were captured by the Typhoon Variable Mode Imager 9400 (GE Amersham) and analyzed with DeCyder Differential Analysis Software v6.5 (GE Amersham). A threshold limit of a 3-fold difference was selected as the statistically significant quantitative change, and a pairedsamples t-test at 95% statistical confidence (significance level, P <0.05) was set. In-gel tryptic digestion of silver-stained 2D proteins was carried out with 5 ng/μl Promega Sequencing Grade Modified Trypsin in 10 mmol/L NH4HCO3 and subsequently sequenced using mass spectroscopy (4800 Proteomics Analyzer; Applied Biosystems). Western blotting analysis Immunoblots of tissue lysates were prepared as previously described.2 Briefly, proteins were resolved by 2D gel electrophoresis, blotted onto PVDF membranes, and incubated with antibodies against CRABP2 (1:1000), FABP5 (1:1000), and β-actin (1:1000). Statistical analysis Statistically significant differences among the groups were analyzed by a one-way analysis of variance and pairedsamples t-test for multiple comparisons. Statistical analyses were performed using the SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA). A P <0.05 were deemed to indicate statistical significance. RESULTS 2D DIGE and MALDI-TOF/TOF MS As analyzed by 2D DIGE, 71 protein spots were differentially expressed in BC tissues compared with adjacent non-tumor tissues. The spots with obviously different intensities were excised from the gels and digested with trypsin for MS analysis; 63 proteins were identified using MALDI-TOF/TOF MS. Of these, 21 proteins were significantly more abundant in bladder cancer tissues than in the adjacent non-tumor tissues (Table 1).Table 1: Twenty-one unique proteins overexpressed in BC (>four fold change, P <0.01) were identified with MALDI-TOF/TOF MSOverexpression of cellular retinoic acid-binding protein 2 (CRABP2) and fatty acid-binding protein 5 (FABP5) Two protein with significantly increased expression levels in BC tissues compared with adjacent non-tumor tissues were identified as CRABP2 and FABP5, with high MASCOT scores and sequence coverage (Table 1, Figure 1A). The mass spectra of the tryptic digests of CRABP2 and FABP5 are shown in Figure 1B.Figure 1.: Overexpression of CRABP2 and FABP5. A: The 2DE profiles of CRABP2 and FABP5 (black circles) show differential expression in BC (T) versus adjacent non-tumor (N) tissues. B: MALDI-TOF/TOF MS maps for CRABP2 and FABP5. C: Representative Western blots of four matched pairs of tissues are shown. D: Densitometric analysis of CRABP2 and FABP5 protein levels in BC and corresponding non-tumor tissue samples. *P <0.001.CRABP2 and FABP5 validation by Western blotting To confirm the 2D DIGE results, CRABP2 and FABP5 were analyzed by Western blotting. As shown in Figure 1C and 1D, the BC tissues overexpressed CRABP2 and FABP5 in all 32 tumor tissue lysates compared with levels in adjacent non-tumor tissues. DISCUSSION Recently, proteomics analysis has been used to search for proteins as potential biomarkers of BC, to provide a diagnostic method for replacing cystoscopy and cytology. Potential markers include adipocyte fatty acid-binding protein (A-FABP), bladder cancer associated protein (BLCAP), cystatin B, and p54nrb.3 Some of these markers are highly sensitive or specific in limited samples. However, none are sufficient for the early diagnosis or monitoring of BC. Additional biomarkers that are sensitive and specific for the early diagnosis or monitoring of BC are needed. In the present study, a systemic biological approach combining 2D DIGE with MALDI-TOF/TOF MS identified 21 differently expressed proteins as new potential protein markers for discriminating BC tissues from non-BC tissues. Two of the identified proteins, CRABP2 and FABP5, were obviously differentially expressed in tumor tissue lysates compared with lysates prepared from adjacent non-tumor tissues. CRABP2 is a cytosol-to-nuclear shuttling protein involved in the retinoid signaling pathway. FABP5 is a highly conserved cytoplasmic protein that binds long-chain fatty acids and other hydrophobic ligands. As previously reported,4 all-trans retinoic acid (ATRA) suppressed cancer growth and induced differentiation and apoptosis, and it has been used widely in cancer chemotherapy. Several cytosolic elements influence the biological effects of ATRA, and the two cytosol-to-nuclear shuttling proteins CRABP2 and FABP5 are thought to be central players acting in opposite ways in this process.5 Here, we found that CRABP2 and FABP5 were significantly increased in BC tissues compared with adjacent non-tumor tissues, with high MASCOT scores and sequence coverage. In addition, both CRABP2 and FABP5 were overexpressed in all 32 bladder tumor tissue lysates on Western blotting. In conclusion, we identified that CRABP2 and FABP5 were upregulated in BC tissues and that CRABP2 and FABP5 may serve as potential new biomarkers for BC. Further studies should conducted to clarify their roles in the oncogenesis of BC.